The CenterWatch Weekly, April 04, 2016
Monday, April 4, 2016
Revisiting industry partnerships with the Department of Veterans Affairs
Contract research organizations (CROs) should consider partnering with the Department of Veterans Affairs (VA) when conducting clinical trials, according to an attendee at the recent Clinical Trial Collaborations conference in Boston, Massachusetts. “The atmosphere is right for increasing the number of industry-VA collaborations,” said Dawn McKenna, executive director of the Bedford VA Research Corporation in Bedford, Massachusetts. McKenna spent years working in the pharmaceutical research and development industry as well as government and nonprofit areas before taking the helm in Bedford last year.
Megafunds as an avenue to boost drug development
With skyrocketing drug development costs and increasing pressure on traditional resources, creation of private megafunds to boost drug research seems to be gaining more traction. A recent initiative is an $866 million development fund established by Mitsui & Co., contract researcher Quintiles and other investors.
To read the full articles for this issue of The CenterWatch Weekly, please click here for subscription information.